GIUGGIOLI, DILIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 34.586
EU - Europa 18.092
AS - Asia 16.184
SA - Sud America 2.131
Continente sconosciuto - Info sul continente non disponibili 610
AF - Africa 401
OC - Oceania 45
Totale 72.049
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 33.773
IT - Italia 7.120
SG - Singapore 4.806
GB - Regno Unito 4.685
CN - Cina 4.236
HK - Hong Kong 1.822
BR - Brasile 1.618
VN - Vietnam 1.496
SE - Svezia 1.236
BD - Bangladesh 1.116
DE - Germania 978
FI - Finlandia 888
FR - Francia 777
UA - Ucraina 603
RU - Federazione Russa 579
KR - Corea 559
TR - Turchia 539
CA - Canada 409
IN - India 406
ID - Indonesia 303
NL - Olanda 253
BG - Bulgaria 233
MX - Messico 203
AR - Argentina 190
JP - Giappone 162
ZA - Sudafrica 133
IQ - Iraq 99
ES - Italia 98
IE - Irlanda 96
PL - Polonia 92
AE - Emirati Arabi Uniti 88
PK - Pakistan 82
AT - Austria 70
CO - Colombia 70
EC - Ecuador 67
MY - Malesia 67
BE - Belgio 57
EG - Egitto 53
LT - Lituania 51
CL - Cile 47
MA - Marocco 47
VE - Venezuela 46
SA - Arabia Saudita 45
PH - Filippine 42
TN - Tunisia 42
RO - Romania 41
AU - Australia 40
IR - Iran 38
CR - Costa Rica 33
CZ - Repubblica Ceca 33
JM - Giamaica 33
PE - Perù 32
CH - Svizzera 31
NP - Nepal 31
PY - Paraguay 29
BZ - Belize 28
TH - Thailandia 28
UZ - Uzbekistan 28
KE - Kenya 26
JO - Giordania 24
TW - Taiwan 23
AZ - Azerbaigian 19
AL - Albania 18
ET - Etiopia 17
PT - Portogallo 17
HU - Ungheria 16
OM - Oman 16
DZ - Algeria 15
GR - Grecia 15
BY - Bielorussia 14
HN - Honduras 14
IL - Israele 14
UY - Uruguay 14
BO - Bolivia 13
EU - Europa 13
DO - Repubblica Dominicana 12
LV - Lettonia 12
GT - Guatemala 11
KZ - Kazakistan 11
SN - Senegal 11
BB - Barbados 10
DK - Danimarca 10
PR - Porto Rico 10
PS - Palestinian Territory 10
SC - Seychelles 10
SV - El Salvador 10
TT - Trinidad e Tobago 10
KG - Kirghizistan 9
BH - Bahrain 8
GE - Georgia 8
NG - Nigeria 8
RS - Serbia 8
SY - Repubblica araba siriana 8
EE - Estonia 7
LU - Lussemburgo 7
MD - Moldavia 7
NI - Nicaragua 7
QA - Qatar 7
SI - Slovenia 7
BA - Bosnia-Erzegovina 6
Totale 71.319
Salva come PNG Salva come JPEG
Città #
Southend 3.361
Santa Clara 3.228
Singapore 3.064
Ashburn 3.006
Fairfield 2.600
Hong Kong 1.793
San Jose 1.703
Woodbridge 1.483
Hefei 1.420
Chandler 1.325
Council Bluffs 1.290
Houston 1.228
Jacksonville 954
Seattle 951
Chicago 940
Wilmington 919
Los Angeles 877
Cambridge 829
Ann Arbor 740
London 687
Nyköping 679
Helsinki 668
Beijing 652
Dearborn 622
Milan 586
New York 542
Seoul 507
Ho Chi Minh City 479
Rome 450
Salt Lake City 428
The Dalles 424
Modena 400
Hanoi 376
Izmir 298
San Diego 291
Lauterbourg 253
Buffalo 246
Bologna 240
Princeton 237
Dallas 225
Sofia 224
Jakarta 220
Tampa 199
Columbus 170
Elk Grove Village 168
Moscow 162
Eugene 157
Naples 157
São Paulo 156
Shanghai 155
Frankfurt am Main 153
Atlanta 135
Florence 130
Bremen 120
Orem 114
Palermo 113
Redwood City 104
Des Moines 103
Toronto 102
Phoenix 101
Tokyo 98
Boardman 96
Munich 93
Mexico City 92
Guangzhou 87
Lancaster 81
Dublin 80
Sterling 80
Turin 80
Bari 79
Montreal 79
Catania 78
Parma 77
Denver 75
Detroit 71
Miami 71
Da Nang 70
Warsaw 67
Chennai 66
Kent 65
Johannesburg 64
Genoa 63
Falls Church 59
Haiphong 59
Verona 59
Redondo Beach 54
Amsterdam 52
Brooklyn 52
Reggio Emilia 52
Norwalk 51
Stockholm 51
Manchester 50
Dulles 49
Padova 47
San Francisco 47
New Delhi 44
Mumbai 43
Ovada 43
Belo Horizonte 42
Lappeenranta 42
Totale 46.552
Salva come PNG Salva come JPEG
Nome #
INTERSTIZIOPATIA POLMONARE NON CLASSIFICABILE O SECONDARIA A CONNETTIVITE INDIFFERENZIATA. IMPORTANZA E DIFFICOLTÀ DI UNA DIAGNOSI DIFFERENZIALE. 3.885
ALTERAZIONI CAPILLAROSCOPICHE IN CORSO DI DERMATOMIOSITE E SCLEROSI SISTEMICA; VERSO L’INDIVIDUAZIONE DI PATTERN SPECIFICI 971
HCV-unrelated cryoglobulinaemic vasculitis: the results of a prospective observational study by the Italian Group for the Study of Cryoglobulinaemias (GISC) 789
Thyroid Involvement in Hepatitis C Virus-Infected Patients with/without Mixed Cryoglobulinemia 766
Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients. 496
Evoluzione dello CSURI (Capillaroscopic Skin Ulcer Risk Index) in pazienti affetti da sclerosi sistemica in terapia con antiendotelina-1 e prostanoidi 472
Oxycodone in the Long-Term Treatment of Chronic Pain Related to Scleroderma Skin Ulcers. 454
Bronchoalveolar lavage and response to cyclophosphamide in scleroderma alveolitis. 447
Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases. 447
Systemic sclerosis progression INvestiGation (SPRING) Italian registry: Demographic and clinico-serological features of the scleroderma spectrum 435
Nailfold Videocapillaroscopy Alterations in Dermatomyositis and Systemic Sclerosis: Toward Identification of a Specific Pattern 397
Mixed cryoglobulinemia: Demographic, clinical, and serologic features and survival in 231 patients 397
Effect of treatment with iloprost with or without bosentan on nailfold videocapillaroscopic alterations in patients with systemic sclerosis 396
Systemic sclerosis and cryoglobulinemia: our experience with overlapping syndrome of scleroderma and severe cryoglobulinemic vasculitis and review of the literature. 392
Thymus alterations and systemic sclerosis 388
Heart involvement and systemic sclerosis 386
Hepatitis C virus infection and type 1 and type 2 diabetes mellitus 381
Radiological thymus alterations in systemic sclerosis: our experience and a review of the literature. 380
D-penicillamine in the treatment of eosinophilic fasciitis: case reports and review of the literature. 379
Breast cancer in systemic sclerosis: Results of a cross-linkage of an Italian Rheumatologic Center and a population-based Cancer Registry and review of the literature 375
Incidence of thyroid disorders in systemic sclerosis: results from a longitudinal follow-up. 374
CXCL10 (α) and CCL2 (β) chemokines in systemic sclerosis - A longitudinal study 373
Current treatment of hepatitis C-associated rheumatic diseases. 367
Human parvovirus B19 experimental infection in human fibroblasts and endothelial cells cultures 363
Systemic sclerosis evolution of disease pathomorphosis and survival. Our experience on Italian patients' population and review of the literature 362
COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series 362
Chemokines in the pathogenesis and as therapeutical markers and targets of HCV chronic infection, and HCV extrahepatic manifestations 362
Carotidynia Possibly due to Localized Vasculitis in a Patient with Latent Mycobacterium tuberculosis Infection. 357
Aortic pulse wave velocity measurement in systemic sclerosis patients. 351
Scleroderma digital ulcers complicated by infection with fecal pathogens. 350
Established coronary artery disease in systemic sclerosis compared to type 2 diabetic female patients: a cross-sectional study 350
Cardiac involvement in systemic sclerosis: identification of high-risk patient profiles in different patterns of clinical presentation 349
Elevated Troponin Serum Levels in Adult Onset Still's Disease 345
Correlation of articular involvement, skin disfigurement, and unemployment with depressive symptoms in patients with systemic sclerosis: a hospital sample 344
Cardio-pulmonary disease management in patients with systemic sclerosis: cardio-rheumatology clinic and patient care standardisation proposal 343
Targeting chemokine (C-X-C motif) receptor 3 in thyroid autoimmunity 337
Thyroid involvement in patients with HCV-related mixed cryoglobulinaemia 332
Efficacia di terapia con immunoassorbimento con proteina A dello stafilococco e talidomide in un caso di dermatomiosite refrattaria. 331
Autoimmune and neoplastic thyroid diseases associated with hepatitis C chronic infection 331
Serum 25-OH vitamin D levels in systemic sclerosis: analysis of 140 patients and review of the literature 331
Recombinant human erythropoietin stimulates vasculogenesis and wound healing in a patient with systemic sclerosis complicated by severe skin ulcers. 331
Treatment of severe scleroderma skin ulcers with recombinant human erythropoietin 330
L-Arginine in pregnant scleroderma patients 330
Associations between Systemic Sclerosis and Thyroid Diseases 328
Gynaecological Screening for Cervical and Vulvar Malignancies in a Cohort of Systemic Sclerosis Patients: Our Experience and Review of the Literature 327
Capillaroscopic Skin Ulcers Risk Index (CSURI) calculated with different videocapillaroscopy devices: how its predictive values change 325
SAT0633-HPR Articular Involvement of the Scleroderma Hand: An Assessment Protocol for Planning Occupational Therapy Strategies 325
Antiendothelial cell antibodies induce apoptosis of bone marrow endothelial progenitors in systemic sclerosis 324
Unusual association between Budd–Chiari syndrome secondary to antiphospholipid syndrome and relapsing polychondritis: a case report and review of the literature 324
Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature. 322
Ultrasonography involvement of carotid, upper and lower limb arteries in a large cohort of systemic sclerosis patients 321
Nailfold capillaroscopic changes in dermatomyositis and polymyositis 319
Parvoviral infection of endothelial cells and stromal fibroblasts: a possible pathogenetic role in scleroderma 316
Cryoglobulinemic vasculitis and skin ulcers. Our therapeutic strategy and review of the literature 316
CORRELATION OF A QUANTITATIVE VIDEOCAPILLAROSCOPIC SCORE WITH THE DEVELOPMENT OF DIGITAL SKIN ULCERS IN SCLERODERMA PATIENTS 315
Platelet gel in the treatment of severe scleroderma skin ulcers. 315
Long-term treatment with rituximab in interstitial lung disease related to systemic sclerosis: our clinical experience 312
Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline 308
Brief report: successful pregnancies but a higher risk of preterm births in patients with systemic sclerosis: an Italian multicenter study 303
HHV-6A infection and systemic sclerosis: Clues of a possible association 302
HCV and cryoglobulinemic vasculitis. 300
Insights into the knowledge of complex diseases: Environmental infectious/ toxic agents as potential etiopathogenetic factors of systemic sclerosis 300
Successful treatment with leflunomide of arthritis in systemic sclerosis patients 296
Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: Our interdisciplinary rheumatology-pneumology experience, and review of the literature 296
CLINICAL AND PATHOLOGICAL FEATURES OF BREAST CANCER IN PATIENTS WITH SYSTEMIC SCLEROSIS: PRELIMINARY DATA FROM THE SCLERO-BREAST STUDY 296
Prevalence and evolution of scleroderma pattern at nailfold videocapillaroscopy in systemic sclerosis patients: Clinical and prognostic implications 295
Haematological Malignancies in Systemic Sclerosis Patients: Case Reports and Review of the World Literature 291
Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients 291
Application of Agents Against Interferon-Gamma-Dependent Chemokines in Immunotherapy 290
Cardiovascular risk and prostanoids in systemic sclerosis 288
HCV associated cryoglobulinemic vasculitis 287
Autologous skin grafting in the treatment of severe scleroderma cutaneous ulcers: a case report 285
Management of cardiopulmonary disease in patients with systemic sclerosis: cardiorheumatology clinic and patient care standardization proposal 285
Virus-driven autoimmunity and lymphoproliferation: the example of HCV infection 284
Induction of CXCL10 secretion by interferon-γ and tumour necrosis factor-α and its inhibition by peroxisome proliferator-activated receptor-γ agonists in cultured scleroderma fibroblasts. 284
Micro and nanoparticles as possible pathogenetic co-factors in mixed cryoglobulinemia 284
Polymyositis following Pandemic Influenza A (H1N1) and 2009-10 Seasonal Trivalent Vaccines 283
Amlodipine in the treatment of Raynaud's phenomenon 282
Prediction risk chart for scleroderma digital ulcers: A composite predictive model based on capillaroscopic, demographic and clinico-serological parameters 282
Correlation of a quantitative videocapillaroscopic score with the development of digital skin ulcers in scleroderma patients 280
UNCLASSIFIABLE INTERSTITIAL LUNG DISEASE OR UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE? A CHALLENGING DIFFERENTIAL DIAGNOSIS 280
The link between pain patient and analgesic medication is greater in migraine than in rheumatic disease patients 279
CAPILLAROSCOPIC SKIN ULCER RISK INDEX (CSURI) IN SYSTEMIC SCLEROSIS: RESULTS FROM AN ITALIAN MULTICENTER VALIDATION STUDY 279
Advanced oxidation protein products in serum of patients with systemic sclerosis: a possible indicator of clinical evolution 275
Autonomic dysfunction in systemic sclerosis: time and frequency domain 24 hour heart rate variability analysis 269
Systemic sclerosis following human cytomegalovirus infection 268
Parallel increase of circulating CXCL11 and CXCL10 in mixed cryoglobulinemia, while the proinflammatory cytokine IL-6 is associated with high serum Th2 chemokine CCL2 268
Use of Neem oil and Hypericum perforatum for treatment of calcinosis-related skin ulcers in systemic sclerosis 267
HCV-related rheumatic manifestations and therapeutic strategies 265
Renal Manifestations of Hepatitis C Virus 265
Photobiomodulation Therapy: A New Light in the Treatment of Systemic Sclerosis Skin Ulcers 265
Measuring microangiopathy abnormalities in systemic sclerosis patients: the role of capillaroscopy-based scoring models 264
The safety of iloprost in systemic sclerosis in a real-life experience 264
Micro and Nanoparticles As Possible Causative-Prognostic Co-Factors Of Mixed Cryoglobulinemia Syndrome 263
[The alpha chemokine "Interferon gamma-induced protein 10" (IP-10) in Graves' disease and Graves'ophthalmopathy] 263
Rituximab in the treatment of patients with systemic sclerosis. Our experience and review of the literature 262
Autologous Fat Grafting for the Oral and Digital Complications of Systemic Sclerosis: Results of a Prospective Study 262
Reactive arthritis induced by intravesical BCG therapy for bladder cancer: our clinical experience and systematic review of the literature 261
Scleroderma Digital Ulcers Complicated by Infection with Fecal Pathogens. 260
Hepatitis C virus syndrome: A constellation of organ- and non-organ specific autoimmune disorders, B-cell non-Hodgkin's lymphoma, and cancer 260
Totale 37.558
Salva come PNG Salva come JPEG
Categoria #
all - tutte 278.105
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 278.105
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.819 0 0 353 386 166 334 194 269 463 381 741 532
2022/20235.029 579 419 282 369 592 677 260 478 651 153 324 245
2023/20244.331 184 282 254 492 753 327 363 472 109 237 349 509
2024/202512.041 472 216 243 827 2.233 1.779 830 635 1.329 769 1.254 1.454
2025/202626.057 1.487 901 1.908 3.429 4.661 1.679 2.907 1.147 2.189 2.092 2.084 1.573
2026/20273.030 1.058 1.873 99 0 0 0 0 0 0 0 0 0
Totale 72.049